Form4insider filings, from the source

SEC Form 4 · accession 0001232524-16-000212

Jazz Pharmaceuticals plc · JAZZ

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Karen J Wilson
Officer — SVP, Finance & PAO
Period of report
Feb 25, 2016
Accepted (ET)
Feb 29, 2016 · 7:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Ordinary SharesF2Feb 25, 2016A3,300$0.00A27,027D
Ordinary SharesFeb 26, 2016F285$125.00D26,742D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Incentive Stock Option (right to buy)F4$123.36Feb 25, 2016A739A—Feb 24, 2026Ordinary Shares739739D
Non-Qualified Stock Option (right to buy)F4$123.36Feb 25, 2016A7,511A—Feb 24, 2026Ordinary Shares7,5117,511D

Explanation of responses